Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1

Show other versions (1)

Background and objective: The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally exceeding 13 g/dL during the treatment with erythropoiesis stimulating agents (ESAs). This study evaluated if there was a clinical impact of...

Full description

Bibliographic Details
Main Authors: Alberto Martínez-Castelao, Aleix Cases, Alberto Torre Carballada, Javier Torralba Iranzo, Josep Bronsoms, Martí Vallès-Prats, Daniel Torán Monserrat, Elisabet Masso Jimenez
Format: Article
Language:Spanish
Published: Elsevier 2015-03-01
Series:Nefrología
Subjects:
Anemia
Chronic kidney disease
Hemoglobin
Erythropoiesis-stimulating agents
Observational Study
Online Access:http://www.sciencedirect.com/science/article/pii/S0211699515000326

Internet

http://www.sciencedirect.com/science/article/pii/S0211699515000326

Similar Items